IDH-WILDTYPE GLIOBLASTOMA
Clinical trials for IDH-WILDTYPE GLIOBLASTOMA explained in plain language.
Never miss a new study
Get alerted when new IDH-WILDTYPE GLIOBLASTOMA trials appear
Sign up with your email to follow new studies for IDH-WILDTYPE GLIOBLASTOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for aggressive brain tumors? drug trial targets recurrent glioblastoma
Disease control Recruiting nowThis early-stage trial tests a new drug called ERAS-801 in 10 adults with a type of aggressive brain cancer (glioblastoma) that has come back or worsened. The drug targets a specific protein (EGFR) found on many of these tumor cells and is designed to reach the brain. The main go…
Matched conditions: IDH-WILDTYPE GLIOBLASTOMA
Phase: PHASE1 • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Disease control
Last updated May 17, 2026 02:39 UTC
-
Morning or evening? new study seeks best time for brain cancer pill
Symptom relief Recruiting nowThis study looks at whether taking the chemotherapy drug temozolomide in the morning or evening is practical for people with glioblastoma, a type of brain cancer. About 50 adults who have already had surgery and radiation will be randomly assigned to take their medication either …
Matched conditions: IDH-WILDTYPE GLIOBLASTOMA
Phase: NA • Sponsor: Ottawa Hospital Research Institute • Aim: Symptom relief
Last updated May 17, 2026 02:41 UTC